Head-to-Head Efficacy: What the Trials Show Tirzepatide outperformed injectable semaglutide 1 mg on both A1C and weight endpoints in the only direct comparison trial to date
Saxenda is supplied as a once-daily subcutaneous injection
This could be the perfect opportunity to build lean muscle
Nauck MA, Quast DR, Wefers J, Meier JJ (2021) GLP-1 receptor agonists in the treatment of type 2 diabetesstate-of-the-art
No significant correlations were found between baseline urine sodium excretion, urinary volume, microalbuminuria, or other measures of kidney hemodynamic function and changes in mGFR and SBP
Patients may require stronger pain medication during the initial recovery period, and mild discomfort can persist for several weeks